Search

Your search keyword '"Genetic Vectors"' showing total 142,321 results

Search Constraints

Start Over You searched for: Descriptor "Genetic Vectors" Remove constraint Descriptor: "Genetic Vectors"
142,321 results on '"Genetic Vectors"'

Search Results

1. Systematic multi-trait AAV capsid engineering for efficient gene delivery.

2. Aberrant hippocampal Ca2+ microwaves following synapsin-dependent adeno-associated viral expression of Ca2+ indicators.

3. AAV gene therapy for hereditary spastic paraplegia type 50: a phase 1 trial in a single patient.

4. Perimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector

5. In vivo rescue of genetic dilated cardiomyopathy by systemic delivery of nexilin.

6. Envelope protein-specific B cell receptors direct lentiviral vector tropism in vivo

7. CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency

8. Simultaneous detection and differentiation of classical Muscovy duck reovirus and goose-origin Muscovy duck reovirus by RT-qPCR assay with high-resolution melting analysis.

9. VEGF—Virus Interactions: Pathogenic Mechanisms and Therapeutic Applications.

10. Exploring SARS-CoV-2 infection and vaccine-induced immunity in chronic myeloid leukemia patients: insights from real-world data in Brazil and the United States.

11. Formulation of three tailed bacteriophages by spray-drying and atomic layer deposition for thermal stability and controlled release.

12. Gene therapy for atrial fibrillation.

13. Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy.

14. Chikungunya Virus Vaccines: A Review of IXCHIQ and PXVX0317 from Pre-Clinical Evaluation to Licensure.

15. Trans‐complementation of the viral movement protein mediates efficient expression of large target genes via a tobacco mosaic virus vector.

16. Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study.

17. Optimization of rubber mixture production using a validated technological sequence of methods.

18. A p21 reporter iPSC line for evaluating CRISPR-Cas9 and vector-induced stress responses.

19. Wind power short-term prediction based on digital twin technology.

20. Seroprevalence of binding and neutralizing antibodies against 18 adeno-associated virus types in patients with neuromuscular disorders.

21. Evolution shapes and conserves genomic signatures in viruses.

22. Golden EGG, a simplified Golden Gate cloning system to assemble multiple fragments.

23. Engineered red Opto-mGluR6 Opsins, a red-shifted optogenetic excitation tool, an in vitro study.

24. Precise genetic control of ATOH1 enhances maturation of regenerated hair cells in the mature mouse utricle.

25. Molecular Engineering of Virus Tropism.

26. Circadian regulation of dengue virus transmission and replication: insights into vector activity and viral dynamics.

27. Identified a novel prognostic model of HCC basing on virus signature for guiding immunotherapy.

28. Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy.

29. Therapeutic Efficacy of Nanocarrier‐Mediated Inhalable Gene Transfection for Lung Cancer.

30. Characterization of bi-segmented and tri-segmented recombinant Pichinde virus particles.

31. Association of new onset seizure and COVID‐19 vaccines and long‐term follow‐up: A systematic review and meta‐analysis.

32. Current Status of Biomedical Products for Gene and Cell Therapy of Recessive Dystrophic Epidermolysis Bullosa.

33. Targeted gene delivery systems for T-cell engineering.

34. Retinoic acid-mediated homeostatic plasticity in the nucleus accumbens core contributes to incubation of cocaine craving.

35. Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis.

36. 100 años después de la BCG, vacunas vivas atenuadas frente a la tuberculosis.

37. Intranasal Prime–Boost with Spike Vectors Generates Antibody and T-Cell Responses at the Site of SARS-CoV-2 Infection.

38. Cloning and Expression of Marine a-Glucosidase and Its Preparation of High Purity Panose.

39. Human cytomegalovirus UL18 prevents priming of MHC-E– and MHC-II–restricted CD8+ T cells.

40. Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses.

41. Heritable gene editing in tomato through viral delivery of isopentenyl transferase and single-guide RNAs to latent axillary meristematic cells.

42. Improving transient expression in N. benthamiana by suppression of the Nb-SABP2 and Nb-COI1 plant defence response related genes.

43. Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment.

44. mRNA‐Engineered CD5‐CAR‐γδTCD5‐ Cells for the Immunotherapy of T‐Cell Acute Lymphoblastic Leukemia.

45. Laminar specificity and coverage of viralmediated gene expression restricted to GABAergic interneurons and their parvalbumin subclass in marmoset primary visual cortex.

46. Vector competence of Aedes albopictus field populations from Reunion Island exposed to local epidemic dengue viruses.

47. Intra‐striatal infusion of the small molecule alpha‐synuclein aggregator, FN075, does not enhance parkinsonism in a subclinical AAV‐alpha‐synuclein rat model.

48. Polymers as Efficient Non-Viral Gene Delivery Vectors: The Role of the Chemical and Physical Architecture of Macromolecules.

49. Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery.

50. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles.

Catalog

Books, media, physical & digital resources